Everolimus — Carefirst Caremark
21 indications indexed for this drug.
- Central Nervous System Cancers Including Glioma Including GlView coverage criteria
- Endometrial CarcinomaView coverage criteria
- Histiocytic Neoplasm Subtypes Including Erdheim Chester DiseView coverage criteria
- Hormone Receptor Hr Positive Human Epidermal Growth Factor RView coverage criteria
- Neuroendocrine Tumors Of The Gastrointestinal Tract Lung AndView coverage criteria
- Neuroendocrine Tumors Of The PancreasView coverage criteria
- Progressive And Or Symptomatic Oncocytic H Rthle Cell CarcinView coverage criteria
- Progressive And Or Symptomatic Papillary Or Follicular ThyroView coverage criteria
- Relapsed Advanced Or Stage Iv Renal Cell Carcinoma RccView coverage criteria
- Relapsed Or Refractory Classic Hodgkin LymphomaView coverage criteria
- Residual Unresectable Recurrent Metastatic Or Tumor RuptureView coverage criteria
- Soft Tissue Sarcoma Subtypes Including Perivascular EpitheliView coverage criteria
- Thymic CarcinomaView coverage criteria
- ThymomaView coverage criteria
- Tsc Associated Partial Onset SeizuresView coverage criteria
- Tsc Associated Renal AngiomyolipomaView coverage criteria
- Tsc Associated Subependymal Giant Cell Astrocytoma SegaView coverage criteria
- Tuberous Sclerosis Complex TscView coverage criteria
- Uterine SarcomaView coverage criteria
- Waldenstr M Macroglobulinemia Lymphoplasmacytic Lymphoma PreView coverage criteria
- Well Differentiated Grade 3 Neuroendocrine TumorsView coverage criteria